Sanofi ADR (SNY) concluded trading on Thursday at a closing price of $56.75, with 3.68 million shares of worth about $208.69 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 17.64% during that period and on September 12, 2024 the price saw a loss of about -1.24%. Currently the company’s common shares owned by public are about 2.51B shares, out of which, 2.51B shares are available for trading.
Stock saw a price change of -2.56% in past 5 days and over the past one month there was a price change of 5.92%. Year-to-date (YTD), SNY shares are showing a performance of 14.12% which increased to 3.79% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $42.63 but also hit the highest price of $58.97 during that period. The average intraday trading volume for Sanofi ADR shares is 2.18 million. The stock is currently trading 0.89% above its 20-day simple moving average (SMA20), while that difference is up 6.66% for SMA50 and it goes to 14.40% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sanofi ADR (NASDAQ: SNY) currently have 2.51B outstanding shares and institutions hold larger chunk of about 10.88% of that.
The stock has a current market capitalization of $142.27B and its 3Y-monthly beta is at 0.57. PE ratio of stock for trailing 12 months is 31.29, while it has posted earnings per share of $1.81 in the same period. Its PEG reads 3.48 and has Quick Ratio of 0.65 while making debt-to-equity ratio of 0.33. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SNY, volatility over the week remained 1.22% while standing at 1.05% over the month.
Stock’s fiscal year EPS is expected to drop by -3.52% while it is estimated to increase by 13.84% in next year. EPS is likely to grow at an annualized rate of 9.00% for next 5-years, compared to annual growth of 2.68% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Argus on July 26, 2024 offering a Buy rating for the stock and assigned a target price range of between $55 and $60 to it. Coverage by Morgan Stanley stated Sanofi ADR (SNY) stock as an Equal-weight in their note to investors on January 23, 2024, suggesting a price target of $55 for the stock. Stock get a Hold rating from Stifel on October 30, 2023.
